ObjectiveHealth Launches Feasibility and Recruitment Platform, ObjectiveScreen
ObjectiveHealth has announced the launch of ObjectiveScreen, an AI feasibility and recruitment platform that seeks to provide patient identification, prequalification, and retention.
Powered by ObjectiveHealth’s cloud-based, AI and ML algorithms, ObjectiveScreen allows clinical trial sites to connect directly with patient electronic health records (EHRs). Patient health risks are stratified against evidence-based physiologic and molecular biomarkers so users can identify in the most qualified candidates for specific clinical trials.
Each time an EHR is linked, ObjectiveScreen’s algorithms analyze the health data, updating its clinical knowledge base while qualifying patients for the specific trials.
In addition to EHR analysis, ObjectiveScreen can review other patient data, including risk factors and demographic data such as age, gender, ethnicity and socioeconomic status, which can help identify candidates who may not have a diagnosis.
By linking with a healthcare provider’s scheduling application, users of ObjectiveScreen can arrange prescreen visits. ObjectiveScreen’s texting and calling capabilities allow clinical trial site users to communicate directly with patients about appointment reminders and rescheduling options. Users can also monitor patients over multiple visits and recommend new studies if patients did not qualify for a previous trial.
Reference
ObjectiveHealth Launches ObjectiveScreen, an Artificial Intelligence-Powered Feasibility and Recruitment Platform to Optimize Clinical Trial Performance. (2023, June 8). Business Wire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
